FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 3350

Substance profile for UNII G2M7P15E5P, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
G2M7P15E5P
Preferred term
POLYETHYLENE GLYCOL 3350
Registry number
25322-68-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
221147
PubChem
0
NCIt
C80131
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm221147https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=221147
NCI ThesaurusC80131https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80131
FDA Substance Registration SystemG2M7P15E5Phttps://precision.fda.gov/uniisearch/srs/unii/G2M7P15E5P

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PESZOPICLONE1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5P085a57b6-75f5-4ecc-b831-11383f5f68a73
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5Pc4104df9-2f42-45ed-bf26-112ec418cd6b1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PL-METHYLFOLATE CALCIUM 7.5mg Tablets L-METHYLFOLATE CALCIUM 15mg Tablets4
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 19831
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5Pedf29e02-f3db-4954-9a1a-9f153f9a073f2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE. BUPROPION HYDROCHLORIDE extended-release tablets, USP (SR) for oral use Initial U.S. Approval: 19852
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PPHENELZINE SULFATE TABLETS, USP Novel Laboratories, Inc. Rx Only2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use RECOTHROM safely and effectively. See full prescribing information for RECOTHROM. RECOTHROM, Thrombin topical (Recombinant) Lyophilized Powder for Solution - For Topical Use Only Initial U.S. Approval: 20088
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PFalessa Kit5
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5P2666b95e-667f-471a-9929-9deca27e9cbc2
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PFluocinonide Cream USP, 0.05% Fluocinonide Cream USP, 0.05% (Emulsified Base) Fluocinonide Gel USP, 0.05% Fluocinonide Ointment USP, 0.05%2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMetoprolol Tartrate Tablets USP Rx Only Prescribing Information7
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5Pe47d3094-109e-4295-9833-d1808adfe6e11
Polyethylene Glycol 3350INACTIVE INGREDIENTG2M7P15E5P1be6cd7a-3f9c-4661-85e4-4a310b490ad33
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5Pbcd57d3c-e1c4-474f-a757-ca89b020278b1
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5Pbcd57d3c-e1c4-474f-a757-ca89b020278b1
Polyethylene Glycol 3350INACTIVE INGREDIENTG2M7P15E5P5991bbb4-754f-489e-9708-1ca1b6a4280f2
Polyethylene Glycol 3350INACTIVE INGREDIENTG2M7P15E5P2f764009-5405-4ff5-8223-12d2aedeb2ad2
Polyethylene Glycol 3350INACTIVE INGREDIENTG2M7P15E5P6069e9dd-3549-40cd-9bdc-c702293aa8e32
Polyethylene Glycol 3350INACTIVE INGREDIENTG2M7P15E5P8aeb1434-6a8a-4ac1-9c9a-b488bd4831192
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PDrug Facts7
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PBupropion Hydrochloride Extended-Release Tablets, USP (SR)2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PDrug Facts4
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5Pf23a3dc4-62e9-46d0-a4b7-383dd5e029111
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5Pd327b4ea-a232-4102-bd74-141196f687e08
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20063
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use simvastatin tablets USP safely and effectively. See full prescribing information for simvastatin tablets USP. SIMVASTATIN tablets USP for oral use Initial U.S. Approval: 19911
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA (darunavir) Oral Suspension, for Oral use PREZISTA (darunavir) Tablet, Film Coated for Oral use Initial U.S. Approval – 20062
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PFlunisolide Nasal Solution USP, 0.025%1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PLOSARTAN POTASSIUM TABLETS USP 7364 7365 7366 Rx only7
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use KEPPRA ® safely and effectively. See full prescribing information for KEPPRA. KEPPRA (levetiracetam) tablets, for oral use KEPPRA (levetiracetam) oral solution Initial U.S. Approval: 19993
Polyethylene Glycol 3350INACTIVE INGREDIENTG2M7P15E5PPatterson Topical Anesthetic Strawberry Flavor1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PGemfibrozil Tablets USP, 600 mg Tablet, Film Coated Rx Only2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PDEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PHYDROXYZINE HYDROCHLORIDE TABLETS, USP1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use Azor safely and effectively. See full prescribing information for Azor. Azor (amlodipine and olmesartan medoxomil) tablet, film coated for oral use Initial U.S. Approval: 20075
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PTEVETEN ® HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5Pbe65d31a-87c1-4f37-a55d-7395bfe3642a2
Polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 19597
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5PPolyethylene Glycol 3350 NF Polyethylene Glycol 3350 Powder for Oral Solution2
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5PPolyethylene Glycol 3350 NF Polyethylene Glycol 3350 Powder for Oral Solution2
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5PPolyethylene Glycol 3350 NF Polyethylene Glycol 3350 Powder for Oral Solution1
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5PPolyethylene Glycol 3350 NF Polyethylene Glycol 3350 Powder for Oral Solution1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PAmoxicillin Tablets, USP2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMUPIROCIN OINTMENT USP, 2%1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMethylPREDNISolone Acetate Injectable Suspension, USP1
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5PDrug Facts1
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5PDrug Facts1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PLevetiracetam Tablets1
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PKEPPRA ® (levetiracetam) 250 mg, 500 mg, 750 mg, and 1000 mg tablets 100 mg/mL oral solution1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PAllerNaze TM (triamcinolone acetonide, USP) nasal spray, 50 mcg1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA (darunavir) Tablet, Film Coated for Oral use Initial U.S. Approval – 20063
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS (raltegravir) Tablets Initial U.S. Approval: 20073
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PRECOMBINATE [Antihemophilic Factor (Recombinant)]7
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PTopical Anesthetic Banana Flavor Gel1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5P76678031-5373-498b-b59d-195705e6ac694
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use Ranexa safely and effectively. See full prescribing information for Ranexa. Ranexa (ranolazine) extended-release tablets Initial U.S. Approval: 20062
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PBupropion Hydrochloride Extended-Release Tablets, USP (SR)4
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PThese highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE (irbesartan and hydrochlorothiazide) tablet for oral use AVALIDE (irbesartan and hydrochlorothiazide) tablet, film coated for oral use Initial U.S. Approval: 19972
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PTOLNAFTATE Antifungal Cream1
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5PAFFORDABLE PHARMACEUTICALS LLC PEG-3350 and Electrolytes1
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5PAFFORDABLE PHARMACEUTICALS LLC PEG-3350 and Electrolytes1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMedroxyprogesterone Acetate Injectable Suspension, USP1
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5PPEG-3350 (240 g) and Electrolytes for Oral Solution, USP with flavor pack2
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5PPEG-3350 (240 g) and Electrolytes for Oral Solution, USP with flavor pack2
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5PPEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution with Flavor pack2
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5PPEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution with Flavor pack2
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMUPIROCIN OINTMENT USP, 2%1
Polyethylene Glycol 3350ACTIVE INGREDIENTG2M7P15E5PPOLYETHYLENE GLYCOL 3350 POWDER, FOR SOLUTION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3858
Polyethylene Glycol 3350ACTIVE MOIETYG2M7P15E5PPOLYETHYLENE GLYCOL 3350 POWDER, FOR SOLUTION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3858
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PVENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3320
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PNORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PTEVETEN HCT (EPROSARTAN MESYLATE AND HYDROCHLOROTHIAZIDE) TABLET [ABBVIE INC.]1449
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PCHLOROQUINE PHOSPHATE (CHLOROQUINE PHOSPHATE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PCHLOROQUINE PHOSPHATE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PGRALISE (GABAPENTIN) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PVIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]203
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMETFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ]58
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PTECHNIVIE (OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]53
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMODERIBA (RIBAVIRIN) KIT MODERIBA (RIBAVIRIN) TABLET, FILM COATED [ABBVIE INC.]52
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.]49
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PSIMVASTATIN TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]32
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PPREZISTA (DARUNAVIR) TABLET, FILM COATED PREZISTA (DARUNAVIR) SUSPENSION [JANSSEN PRODUCTS LP]31
POLYETHYLENE GLYCOL 3350ACTIVE INGREDIENTG2M7P15E5PMOVIPREP (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE) KIT [SALIX PHARMACEUTICALS, INC.]30
POLYETHYLENE GLYCOL 3350ACTIVE MOIETYG2M7P15E5PMOVIPREP (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE) KIT [SALIX PHARMACEUTICALS, INC.]30
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PZIDOVUDINE TABLET, FILM COATED [LANNETT COMPANY, INC.]29
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PLEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]23
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PNOXAFIL (POSACONAZOLE) SUSPENSION NOXAFIL (POSACONAZOLE) TABLET, COATED NOXAFIL (POSACONAZOLE) SOLUTION [MERCK SHARP & DOHME CORP.]22
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PLETAIRIS (AMBRISENTAN) TABLET, FILM COATED [GILEAD SCIENCES, INC]20
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PSOLODYN (MINOCYCLINE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [MEDICIS PHARMACEUTICAL CORP.]19
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC]17
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PLOSARTAN POTASSIUM TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]17
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC]17
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PMETHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]17
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PSIMVASTATIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]17
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PXARELTO (RIVAROXABAN) TABLET, FILM COATED XARELTO (RIVAROXABAN) KIT [JANSSEN PHARMACEUTICALS, INC.]17
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PDIVALPROEX SODIUM TABLET, DELAYED RELEASE [AUROBINDO PHARMA LIMITED]16
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PJANUMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.]16
polyethylene glycol 3350INACTIVE INGREDIENTG2M7P15E5PKEPPRA (LEVETIRACETAM) TABLET, FILM COATED KEPPRA (LEVETIRACETAM) SOLUTION [UCB, INC.]16
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PAZOR (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL) TABLET, FILM COATED [DAIICHI SANKYO, INC.]15
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PDIVALPROEX SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]15
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY]14
Polyethylene Glycol 3350INACTIVE INGREDIENTG2M7P15E5PKEPPRA XR (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [UCB, INC.]14
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PLOSARTAN POTASSIUM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]14
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PSTIVARGA (REGORAFENIB) TABLET, FILM COATED [BAYER HEALTHCARE PHARMACEUTICALS INC.]14
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PBENZPHETAMINE HYDROCHLORIDE TABLET [BOCA PHARMACAL, LLC]13
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PGEMFIBROZIL TABLET, FILM COATED [BLU PHARMACEUTICALS, LLC]13
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PHURRICAINE TOPICAL ANESTHETIC (BENZOCAINE) GEL [BEUTLICH PHARMACEUTICALS LLC]13
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PSPIRONOLACTONE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]13
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY]12
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PKALYDECO (IVACAFTOR) TABLET, FILM COATED KALYDECO (IVACAFTOR) GRANULE [VERTEX PHARMACEUTICALS INCORPORATED]12
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PLEVETIRACETAM TABLET, FILM COATED [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]12